2025 annual financial data
Avalyn Pharma 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -91,292,000 USD and net income was -85,204,000 USD.
Operating cash flow was -81,484,000 USD.
Get free Avalyn Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -91,292,000 USD
- Net income
- -85,204,000 USD
- Operating cash flow
- -81,484,000 USD